Enyerela JYMed patent nke Europe maka usoro njikọ mmepụta ya nke Liraglutide. Ihe ịrịba ama a na-eme ka onye ndu anyị na-aga n'ihu na peptide R&D na IP. Patent a na-anọchi anya usoro ọhụrụ maka synthesizing liraglutide, nke ọ bụghị naanị na-eme ka mkpụrụ osisi kwụsie ike kamakwa na-ebelata nke ukwuu nguzobe nke adịghị ọcha agbụrụ [D-Thr ^ 5]-Liraglutide, nke yiri ngwaahịa e lekwasịrị anya. Ihe ọhụrụ a na-eme ka ogo ngwaahịa ahụ dịkwuo mma.

Nnweta nke European patent na-egosiputa ikike R&D zuru oke nke ụlọ ọrụ ahụ, na-eme ka uru teknụzụ ya sie ike. Ọ na-enye aka n'ịkwalite asọmpi isi nke JYMed na ịgbasa ọnụnọ ya n'ahịa mba ụwa. Na mgbakwunye, ọ na-ewusi uru akụrụngwa ọgụgụ isi nke ụlọ ọrụ ahụ ike, na-enyere aka idobe ma kwalite asọmpi ahịa ahịa zuru ụwa ọnụ.

Hubei JXBio Pharmaceutical Co., Ltd, onye enyemaka nke Shenzhen JYMed Technology Co., Ltd, enwetala ọkwa nnabata ahịa maka Oxytocin Active Pharmaceutical Ingredient (API) nke National Medical Product Administration (NMPA) nke China nyere.

Nkwenye a na-egosi na JXBio's oxytocin API na-emezu ihe achọrọ teknuzu usoro iwu nke usoro nleba anya ọgwụ obodo setịpụrụ. Ọ na-egosi akara ngosi dị mkpa maka ụlọ ọrụ ahụ, na-emewanyewanye Pọtụfoliyo ngwaahịa ya ma na-enye ntọala siri ike maka mgbasawanye ahịa na mpaghara oxytocin.
Banyere JYMED
JYMed bụ a elu-tech biopharmaceutical ụlọ ọrụ pụrụ iche na onwe nnyocha, mmepe, mmepụta, na ahịa nke peptide dabeere na ngwaahịa, nakwa dị ka nkwekọrịta mmepe na n'ichepụta nzukọ (CDMO). Ụlọ ọrụ ahụ na-agba mbọ ịnye API peptide dị elu yana ngwọta ahaziri maka ndị ahịa ụwa. Pọtụfoliyo ngwaahịa ya gụnyere ọtụtụ peptide API, yana ngwaahịa ndị dị ka Semaglutide na Terlipressin emechaala akwụkwọ US FDA DMF.

Ndị enyemaka ya,Hubei JXBio Pharmaceutical Co.,Ltd., na-arụ ọrụ ahịrị mmepụta peptide API ọgbara ọhụrụ na-agbaso ụkpụrụ cGMP nke US FDA, European EMA, na NMPA nke China setịpụrụ. Ụlọ ọrụ ahụ na-agụnye ahịrị mmepụta 10 nnukwu na pilot ma guzobe usoro nlekọta ahụike siri ike (QMS) na usoro nlekọta ahụike na nchekwa gburugburu ebe obibi (EHS). Ndị a na-achọpụta na usoro dum, site na R&D ruo mmepụta, na-ezute ụkpụrụ mba ụwa kachasị elu. Ụlọ ọrụ ahụ agafeela nyocha nnabata GMP site na US FDA na NMPA nke China na ndị ụlọ ọrụ na-ahụ maka ọgwụ zuru ụwa ọnụ nabatara ya maka ịdị mma njikwa EHS ya, na-egosipụta nraranye ya pụtara ìhè n'ịdị mma, nchekwa, na ọrụ gburugburu ebe obibi.

Mpaghara azụmahịa isi:Ndebanye aha na nnabata API peptide ụlọ na mba ofesi,Ọgwụ anụmanụ na ịchọ mma peptides,Ọrụ peptide ahaziri ahazi, gụnyere CRO, CMO na ngwọta OEM,Njikọ ọgwụ Peptide (PDCs), gụnyere peptide-radionuclide, peptide-small molecule, peptide-protein, na peptide-RNA ọgwụgwọ..

Isi ngwaahịa

Maka nkọwa ndị ọzọ gbasara ngwaahịa anyị, biko kpọtụrụ anyị.

API zuru ụwa ọnụ na ajụjụ ịchọ mma: Tel No.: +86-15013529272;

Ndebanye aha API & Ọrụ CDMO (ahịa USA EU): +86-15818682250

Email:jymed@jymedtech.com

Adreesị: Ụlọ elu 8 & 9, Ụlọ 1, Shenzhen Biomedical Innovation Industrial Park, 14 Jinhui Road, Kengzi Subdistrict, Pingshan District, Shenzhen